Nobel prize-winning scientists to speak in London

Nobel prize-winning scientists to speak in London

World renowned virologist and Nobel laureate Prof Luc Montagnier will be among a number of scientists attending an international seminar in London to discuss the latest groundbreaking research into the properties of water.

Professor Montagnier was awarded the Nobel Prize for Medicine in 2008 for discovering HIV. The French scientist has since become a leading authority in water research, and when interviewed in 2010 said: “High dilutions of something are not nothing, they are water structures which mimic the original molecules. It’s not pseudoscience. It’s not quackery. These are real phenomena which deserve further study.”

He will be revealing the results of his latest research at the Royal Society of Medicine in London on Saturday 14 July 2018. The seminar is open to the public and tickets cost £95.

Another Nobel prize-winner, Emeritus Prof Brian Josephson, Cambridge University, will also be speaking at the event. He has expressed support for Jacques Benveniste’s theory of the “memory of water”, which some believe could explain the method of action of homeopathic medicines.

Travelling from America is Honorary Prof Gerald Pollack of the University of Washington. Dr Pollack is a professor in bioengineering and an expert in water science who discovered the fourth phase of water known as EZ water.

Completing an impressive international line-up are two leading researchers from Russia – Prof Vladimir Voeikov and Prof Alexander Konovalov. Prof Voeikov is renowned in the field of physical and chemical properties of aqueous systems and their key role in the vital processes in living systems; while Prof Konovalov has conducted independent research on high dilutions that could provide a better scientific understanding of homeopathy.

An honorary dinner for the visiting scientists will take place at the House of Lords on Friday 13 July to which the public is also invited. Further details about attending the House of Lords dinner and the seminar are available at thesciencetheevidence@gmail.com.

More information can be found at http://thesciencetheevidence.co.uk.

Australian Government blocks homeopathy ban

Australian Government blocks homeopathy ban

Popular natural treatments used to manage hay fever, stress, insomnia, joint aches, teething, and other medical conditions will continue to be sold on pharmacy shelves after a landmark win for consumers.

In June last year a report to the Federal Government recommended natural medicine and treatments, including homeopathic products, be banned or restricted from sale in pharmacies.

Tens of thousands of consumers protested with nearly 80,000 people joining the Your Health Your Choice campaign to call on the Government to protect their right of choice to access natural medicines.

At the Australian Pharmacy Professional Conference on the Gold Coast on May 3, Federal Health Minister Greg Hunt released the Government’s response amid a raft of reform announcements.

The proposed ban was part of the Review of Pharmacy Remuneration and Regulation, known as the King Review which suggested banning homeopathic products and placing restrictions on the sale of other complementary medicine products in PBS pharmacies.

UK Charity takes NHS England to Court

UK Charity takes NHS England to Court

The British Homeopathic Association (BHA) – a charity that supports patients’ rights to homeopathic treatment on the NHS – is awaiting judgement on its legal challenge to NHS England’s 2017 consultation that ended with a recommendation that GPs should not prescribe homeopathic medicines.

After just over three days of lengthy and detailed legal arguments at the Royal Courts of Justice, London, Mr Justice Supperstone adjourned the court to consider his judgement.

Cristal Sumner, BHA chief executive, said: “We are confident of a positive outcome. We took the difficult decision to bring this case because we had ample evidence to demonstrate NHS England failed to properly consult on its proposal to ban prescriptions for homeopathic medicine which, since being implemented, has had an adverse effect on patients’ health.”

The BHA commenced an application for judicial review in October 2017 on the basis that NHS England’s consultation was fundamentally flawed from the outset. It is the charity’s case that the proposal was not formulated with input from any homeopathy experts or practitioners; it was not a genuine attempt to engage the public; and did not provide the public with adequate information or access to provide a considered and informed response.

Whatever the judge’s decision, the BHA through its challenge has made it clear that the NHS needs to be accountable to the public and the patients who use its services.

The judge’s ruling is expected in the coming weeks.